• Explore /
  • Poster
  • / AcSé-ESMART: “European Proof of Concept Therapeutic Stratification trial of Molecular Anomalies in Relapsed or Refractory Tumors in children and adolescents” –ARM D: Olaparib and Irinotecan.

AcSé-ESMART: “European Proof of Concept Therapeutic Stratification trial of Molecular Anomalies in Relapsed or Refractory Tumors in children and adolescents” –ARM D: Olaparib and Irinotecan.

Abstract Poster

Authors

null

Susanne Andrea Gatz

University of Birmingham, Birmingham, United Kingdom

Susanne Andrea Gatz , Jonathan Rubino , Caroline Rossoni , Nicolas Andre , Isabelle Aerts , Estelle Thebaud , Souad Nebchi , Windy Rondof , Daniel Hübschmann , Peter G. Mortimer , Xavier Paoletti , Gilles Vassal , Birgit Geoerger

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Pediatric Oncology

Track

Pediatric Oncology

Sub Track

Pediatric Solid Tumors

Clinical Trial Registration Number

NCT02813135

Citation

J Clin Oncol 37, 2019 (suppl; abstr 10047)

DOI

10.1200/JCO.2019.37.15_suppl.10047

Abstract #

10047

Poster Bd #

429

Abstract Disclosures

Similar Posters

First Author: Ecaterina Elena Dumbrava

First Author: Sara Michele Federico

First Author: Giovanni Grignani

First Author: Anthony J. Chalmers